Haemophilia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older
- You have been diagnosed with hemophilia A or B
- You are currently receiving regular (preventive) treatment with clotting factor medicines, whether standard or longer-acting versions, regardless of how mild or severe your hemophilia is
- You have been on the same treatment routine continuously for at least six months before joining the trial
Who may not be able to join:
- You have developed antibodies (called inhibitors) that work against your factor VIII or factor IX treatment, making it less effective
- You have also been diagnosed with another serious long-term condition, such as a severe neurological, cancer-related, severe psychiatric, or rheumatological disease, that could affect how you experience your treatment or daily life
- You have difficulties with thinking, language, or senses that would make it hard to understand and fill in questionnaires correctly
- You are currently taking part in another clinical trial or a special monitoring programme that might change how you feel about your treatment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rubén Cuesta-Barriuso, PhD, Universidad de Oviedo
Phone: 0034 985103386
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Assessment of treatment burden at the time of the study.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.